The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Highly Potent, Water Soluble Benzimidazole Antagonist for Activated alpha(4)beta(1) Integrin.BDB
University of California Davis
Small molecule inhibitors of integrin alpha2beta1.BDB
University of Pennsylvania
Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists.BDB
Daiichi Pharmaceutical
Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists.BDB
Daiichi Pharmaceutical
Selection of a 2-azabicyclo[2.2.2]octane-based alpha4beta1 integrin antagonist as an inhaled anti-asthmatic agent.BDB
Johnson & Johnson Pharmaceutical
2,6-Quinolinyl derivatives as potent VLA-4 antagonists.BDB
Ucb Pharma
Pyridone derivatives as potent and selective VLA-4 integrin antagonists.BDB
Glaxosmithkline
Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists.BDB
Glaxosmithkline
Structure-activity relationship studies of a series of peptidomimetic ligands for alpha(4) beta(1) integrin on Jurkat T-leukemia cells.BDB
University of California Davis
Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonists.BDB
Johnson & Johnson Pharmaceutical
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists.BDB
Johnson & Johnson Pharmaceutical